Patents by Inventor Pamela Michelle Pollock

Pamela Michelle Pollock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof
    Patent number: 9254288
    Abstract: This disclosure provides tyrosine kinase protein and nucleic acid variants, particularly FGFR2 variants, which are linked to drug resistance. The disclosure further provides methods of diagnosis and theranosis, using these molecules and fragments thereof, and kits for employing these methods and compositions.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: February 9, 2016
    Assignees: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, QUEENSLAND UNIVERSITY OF TECHNOLOGY
    Inventor: Pamela Michelle Pollock
  • Methods of determining susceptibility of tumors to tyrosine kinase inhibitors
    Patent number: 9140689
    Abstract: This disclosure provides tyrosine kinase protein and nucleic acid variants, particularly FGFR2 variants, which are linked to drug resistance. The disclosure further provides methods of diagnosis and theranosis, and development of new therapeutic agents using these molecules and fragments thereof, and kits for employing these methods and compositions.
    Type: Grant
    Filed: March 14, 2011
    Date of Patent: September 22, 2015
    Assignees: Translational Genomics Research Institute, Queensland University of Technology
    Inventors: Sara Ann Byron, Pamela Michelle Pollock
  • SUSCEPTIBILITY OF TUMORS TO TYROSINE KINASE INHIBITORS AND TREATMENT THEREOF
    Publication number: 20130296326
    Abstract: This disclosure provides tyrosine kinase protein and nucleic acid variants, particularly FGFR2 variants, which are linked to drug resistance. The disclosure further provides methods of diagnosis and theranosis, using these molecules and fragments thereof, and kits for employing these methods and compositions.
    Type: Application
    Filed: May 7, 2013
    Publication date: November 7, 2013
    Applicant: TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventor: Pamela Michelle Pollock
  • METHODS OF DETERMINING SUSCEPTIBILITY OF TUMORS TO TYROSINE KINASE INHIBITORS
    Publication number: 20110275084
    Abstract: This disclosure provides tyrosine kinase protein and nucleic acid variants, particularly FGFR2 variants, which are linked to drug resistance. The disclosure further provides methods of diagnosis and theranosis, and development of new therapeutic agents using these molecules and fragments thereof, and kits for employing these methods and compositions.
    Type: Application
    Filed: March 14, 2011
    Publication date: November 10, 2011
    Applicant: The Translational Genomics Research Institute
    Inventors: Sara Ann Byron, Pamela Michelle Pollock